The Context: Aims: To evaluate the biocompatibility and in vitro genotoxicity of a non-copper nano silica polymer modified composite for filtering-type intra-vas devices. Settings and Design: Academic research laboratory, Huazhong University of Science and Technology. Prospective experimental study. Methods and Material: Non-copper nano silica polymer modified composite rods were implanted into the back muscle of rabbits for biocompatibility evaluation. Comet assay was applied to the determination of DNA damage, while, Mutagenic activity was tested by means of Ames test using Salmonella typhimurium TA98 and TA100 tester strains with and without metabolic activation. Statistical analysis used: qualitative and quantitative data were tested using the Chi-square test and Student's test. Results: Only mild inflammatory reaction was observed in the surrounding tissues of the implanted nano-silica modified polymer composite in the early implantation stage, which was similar to that of the sham-operated group. The inflammatory reaction was completely disappeared after 12 weeks. No significant DNA damage (P > 0.05) was tested on the nano-silica modified polymer composite in Comet assay. In Ames test, the extracts from non-copper composite did not exert mutagenic effect on the bacterial. Conclusions: The non-copper nano silica modified composite did not exhibit in vitro genotoxicity and obvious inflammation in tissue, it would be a safe biomaterial for further clinical trial.
Introduction
Filtering-type intra-vas devices (IVD) as possible alternatives of vasectomy have been attracted researchers to keep exploring new configurations and novel biomaterials for it [1, 2] . Recent reports exhibiting that copper ions may have genotoxicity on mammalian cells [3] [4] [5] prompted us to improve constitutes of the novel contraceptive composite specifically suitable for filtering-type IVDs. In the previous study, we did not find significant changes of copper ions in dog's semen after the copper-containing composite IVD implanted for 12 months [2] , so copper ions in the composite may not be a necessary. By keeping the characteristics of filtering function and all other components of the composite except copper chloride, we produced the non-copper microporous polymer composite and tested on its biocompatibility and genotoxicity to meet the harsh requirement for clinical trial.
Subjects and Methods

Chemicals
The PVA used in the study was supplied by Shanxi Sanwei Group Co. Ltd., China (polymerization ~2400 and where colloid particles are dispersed homogeneously in water, provided by the Secondary Chemical Factory of Wuhan, China. The content of silica is 30 wt% and the particle size is about 10 nm degree of hydrolysis ~99%). Silica sol is a colloid solution.
Fetal bovine serum(FBS) was from Gibco and Trypan blue were obtained from Sigma (St. Louis, MO, USA), dimethyl sulfoxide (DMSO) and ethidium bromide (EB) were procured from Amresco (Solon, OH, USA). Parenzyme was from Amresco (Solon, OH). All other reagents, of analytical grade or higher, were purchased from Shanghai Chemical Company (Shanghai, China), unless otherwise noted.
Cell Line
The TM4 cell line was purchased from the American Type Culture Collection (CRL-1715, ATCC, Manassas, VA). These cells derived from Sertoli cells of murine testis, represent an appropriate cell model to investigate the link between toxicity of contraceptive material and reproductive system.
Nano-Silica Modified Polymer Composite
and IVD Prototype
Preparation of Non-Copper Composite
The preparation of PVA solution: aqueous 10 wt% PVA solutions were prepared by soaking pre-weighed quantities of dry PVA in de-ionized water for 6 h and heating at 90˚C for 1 h. The modification of PVA: silica sol was then mixed with the previously prepared PVA solution by stirring at 80˚C for 1 h to obtain a homogeneous solution. PVA was modified by silica to decrease its solubility and enhance its mechanical properties. The mixture was continuously stirred at 50˚C for 0.5 h. After that, the mixture was poured into a clean and slick glass plate and placed in the ventilation cupboard for about 2 days to allow the solvent to evaporate.
Producing of the Filtering-Type IVD Prototype Except for mixing of copper chloride, the detailed procedures of producing filtering-type IVD prototype were as described as in our previous study [2] . The specifications of the filtering-type IVD were modified as follow:
outer diameter: 0. 
Preparation of the Extracts
The non-copper composite sample was first disinfected with ethylene oxide and then put into phosphate-buffered saline solution (PBS) or culture medium supplemented with 10% FBS, and penicillin-streptomycin solution (100 U penicillin and 100 mg of streptomycin per mL) at the ratio of 1.0 g sample in 5 mL solution. After the sample was soaked for 24 hours in a 37˚C incubator, the solution was disinfected and stored at 4˚C.
Implantation Test
Fifteen healthy adult New Zealand white rabbits (Wuhan University Laboratory Animal Center, China), body weight 3.0 -4.0 kg, were employed in the experiment. The animals were divided into three groups of different implantation periods (1, 4, and 12 wk), with five animals tested at each time period. All animal experimental procedures were carried out in accordance with the Guidelines and Regulations for the Use and Care of Animals of the Review Board of Huazhong University of Science and Technology. Each animal was anesthetized by an intraperitoneal injection of sodium pentobarbital (30 mg/kg body weight). The biomaterial was then implanted into the spinal muscle of the rabbits at four points, at 2-cm intervals, and the material inserted into the muscle at a 1 -2 cm in depth. The contralateral side was sham-operated. Rabbits were sacrificed by CO 2 asphyxiation sequentially at 1, 4, and 12 weeks after the implantation. Both sites of the spinal muscles adjacent to the nanosilica modified polymer composite were carefully excised from the surrounding tissue and immersed in 10 vol% buffered formalin solution for 48 hours. The specimens were paraffin embedded. Six-micrometer serial sections were obtained and stained with hematoxylin and eosin. The stained sections were assessed with light microscopy (Olympus, Germany).
Trypan Blue Exclusion Assay
To verify whether samples are non-cytotoxic on the basis of MTT, we investigated cell viability of selected concentration suitable for genotoxic evaluation using Trypan blue exclusion assay [6] , which was just prior to performing alkaline comet assay. 100 μl of cell suspension was mixed with 100 μl of Trypan blue (0.4%, w/v). Thereafter, the viable (transparent) and nonviable (blue) cells were counted by immediate microscopic observation using a hemocytometer.
Alkaline Single Cell Gel Electrophoresis Assay
Comet assay is a versatile, sensitive, and rapid method for measuring DNA single-and double-strand breaks at the level of individual cells and is the most frequently used genotoxicity test for chemicals. As described by [7] , TM4 cell samples were suspended in 0.7% low melting agarose (100 μl) and applied to the prepared slides. Then slides were immersed in prechilled lysis buffer (2.5 M NaCl, 100 mM Na 2 EDTA, 200 mM NaOH, 10 mM Trisbase, 1% TritonX-100, and 10% DMSO) for 1.5 h. Following a 20-min DNA unwinding period, the electrophoresis was performed in alkaline buffer for 25 min. After neutralization in 0.4 M Tris-base buffer (PH 7.5), cells were stained with ethidium bromide (20 μg/mL). At least 150 cells per concentration were randomly selected and captured at 200× magnification using fluorescence microscope Olympus BX51 (Olympus, Tokyo, Japan) equipped with an Olympus DP71 (Olympus, Tokyo, Japan) digital color camera. For quantitative analysis, Comet assay software project, CASP software [8] was utilized, and the Olive Tail Moment (OTM), preconised by Olive [9] , was chosen to characterize DNA damage in individual cells.
Ames Test
Two tester strains, TA98 and TA100, were supplied by the laboratory of Dr. B. Ames (University of California, Berkeley, CA, USA), and their genotypes were checked regularly. It is noteworthy that, in Ames test, simulated body fluid (SBF, PH 7.4) with concentration similar to those of human blood plasma was utilized as extraction buffer to mimic the post-implant environment [10] . A standard plate incorporation procedure was utilized in the presence and absence of Aroclor1254-induced rat liver homogenate preparation (S9). In brief, TA98 and TA100 were cultured in nutrient broth for 10 h at 37˚C under agitation. Thereafter, 500 μl of S9 mix (or 500 μl of phosphate buffer), 100 μl of different concentrations of extracts and 100 μl of bacterial culture were added to 2.5 mL top agar and vortexed for 3 s. Then the mixture was poured onto a minimal agar plate. The plates were incubated at 37˚C for 48 h. Following this, the revertant bacterial colonies on each plate were counted.
Data Analysis
All data were analysed using the spss (v16.0; Chicago, IL, USA). Qualitative and quantitative data were tested using the Chi-square test and Student's test, respectively. P < 0.05 was considered statistically significant.
Results
Implanting Test
For all of the rabbits, the insertion hole could still be found on the muscle fascia for all implants after 1, 4, and 12 weeks. After 1 week of implantation, the implants were located in a muscular pocket that was clearly separated from the surrounding tissue. At 4 weeks, fibrous tissue formation started resulting in encapsulation of the implanted material. At 12 weeks, the implants adhered tightly to the surrounding tissue, and the area of the implantation resembled the surrounding original tissue. Light micrographs of histologic sections after 1, 4, and 12 weeks of implantation are shown in Figure 2. 
Trypan Blue Assay
Before performing the comet assay, viability of TM4 cells was estimated using trypan blue exclusion. Light microscopic examination of the cells after staining with trypan blue demonstrated stable viability over all the concentrations used for genotoxicity tests, with percent viability consistently over 90% in all samples.
Alkaline Comet Assay
The OTM was assayed as a measure of DNA-strand breaks in the SCGE assay. As seen in Figure 3 , without affecting the cell viability, extractables of the nano-silica modified polymer composite were not found to induce significant DNA damage (P > 0.05) at all concentrations compared to the control. 
Ames Test
All the concentrations (100%, 50%, 25%, and 12.5%) of the nano-silica modified polymer composite were pre- pared by a serial dilution. As summarized in Table 1 , the number of revertant colonies did not exceed the threshold of twice the number of the solvent control following exposure to the composite extracts in all of the concentrations in TA98, with and without S9-mix. Following treatment in the TA100 strain, no significant increase in the incidence of revertant colonies was observed at all concentrations in the presence and absence of S9-mix. As a matter of fact, comparison of mutagenicity ratio (MR) between the nano-silica modified polymer composite and the negative control indicated no significant difference at any concentration in the presence or absence of metabolic activation, but there are significant differences to the positive controls.
Discussion
The experimental biomaterials were regarded to be biocompatible if the intensity of connective reaction decreased over time. Consequently, to be considered biocompatible, at 90 days the connective tissue surrounding the implant must show a thin fibrous capsule formation surrounding the tube as well as an absence of inflammatory reaction and/or macrophages/giant cells. On the other hand, the material is considered to be non-biocompatible when a persistent inflammatory reaction occurs related to macrophages and giant cells with a thick fibrous capsule development even at 90 days after implantation. So as the result exhibited, the nano-silica modified polymer composite is histocompatible.
When the toxicity of a composite is concerned, we need to evaluate all of its major constituents. Firstly, the nanoparticles of silica was paid attention to, because it is widely used in food and biomaterials nowadays. The response of several normal fibroblast and tumor cells to varying doses of amorphous silica or composite nanoparticles of silica and chitosan was investigated [11] . A cell proliferation assay indicates that silica nanoparticles are nontoxic at low dosages but that cell viability decreases at high dosages. A lactate dehydrogenase assay indicates that high dosages of silica induce cell membrane damage [11] . Endothelial cells exposure to silica nanoparticles causes cytotoxic damage and a decrease in cell survival in the EAHY926 cell line in a dose-related manner [12] . Cytotoxicity profile of silica nanoparticles has received experimental support in different model cell lines, which was considered to be the result of size-/dose-dependent effect and oxidative stress provoked by these particles [13] . Whereas Morishige T. et al. [14] did not observe cell death when treated with silica nanoparticles (30-, 50-, 70-nm). On the other hand, a recent study reported that amorphous silica nanoparticles elicited chromosomal aberrations and gene mutations [15] . However, there are conflicting reports such as the one which did not observe silica nanoparticles-induced genotoxic hazard using a Comet assay [16] . Overall, the available experimental data do not fully characterize the cytotoxic and genotoxic potentials of amorphous silica nanoparticles by virtue of these discrepancies. In a recent study, no significant amorphous silica nanoparticles-related cyto-and genotoxic response was observed, which may be, in part, due to relatively low dosage loaded and sol-gel-derived silica that minimize silica dissolution and improve the biocompatibility [17] . The silica nanoparticles we used were cross-linked with PVA, the dosage was low, and the gravitational force between molecules also may limit their effluence from the complex, possible explaining why no significant cytotoxicity and genotoxicity were observed in this nano-silica modified polymer composite.
In conclusion, results from the biocompatibility and in vitro genotoxicity tests of the non-copper composite demonstrated that this nano-silica modified polymer composite is histocompatible and non-genotoxic. As it is as the same configuration and function as the copper-containing composite IVD which has exhibited effective contraceptive effects, the nano-silica modified non-copper polymer composite IVD would be a safe and promising alternative to the operation of vasectomy.
